CAPE and artepillin C have been shown to bind mortalin–p53 complexes, thereby activating p53 and inducing growth arrest in human fibrosarcoma (HT1080), lung cancer (A549), and osteosarcoma (U2OS) cells [113]. This evidence concerns the gene TP53 and lung carcinoma.